Evidence map›Paper›PMID 21326834›Full record

ArticleBioengineered bugs

Transgenic organisms expressing genes from Bacillus thuringiensis to combat insect pests.

Arieh Zaritsky, Eitan Ben-Dov, Dov Borovsky, Sammy Boussiba, Monica Einav, Galina Gindin, A Rami Horowitz, Mikhail Kolot, Olga Melnikov, Zvi Mendel and 1 more

Open access · bronzeAbstract readEvaluation Study
In one paragraph

Article in Bioengineered bugs. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Inhibitory activity ofBioengineered · 2022
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Arieh ZaritskyDepartment of Life Sciences, Ben-Gurion Universiy of the Negev at Be'er-Sheva, S'de-Boker, Israel. ariehz@bgu.ac.il
Eitan Ben-Dov
Dov Borovsky
Sammy Boussiba
Monica Einav
Galina Gindin
A Rami Horowitz
Mikhail Kolot
Olga Melnikov
Zvi Mendel
Ezra Yagil
Ben-Gurion University of the Negev · ILAgricultural Research Organization · ILTel Aviv University · ILUniversity of Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Various subspecies (ssp.) of Bacillus thuringiensis (Bt) are considered the best agents known so far to control insects, being highly specific and safe, easily mass produced and with long shelf life.1 The para-crystalline body that is produced during sporulation in the exosporium includes polypeptides named δ-endotoxins, each killing a specific set of insects. The different entomopathogenic toxins of various Bt ssp. can be manipulated genetically in an educated way to construct more efficient transgenic bacteria or plants that express combinations of toxin genes to control pests.2 Joint research projects in our respective laboratories during the last decade demonstrate what can be done by implementing certain ideas using molecular biology with Bt ssp. israelensis (Bti) as a model system. Here, we describe our progress achieved with Gram-negative bacterial species, including cyanobacteria, and some preliminary experiments to form transgenic plants, mainly to control mosquitoes (Diptera), but also a particular Lepidopteran and Coleopteran pest species. In addition, a system is described by which environment-damaging genes can be removed from the recombinants thus alleviating procedures for obtaining permits to release them in nature.

Indexed as

Gene ExpressionAnimalsBacillus thuringiensis ToxinsBacterial ProteinsCulicidaeCyanobacteriaEndotoxinsHemolysin ProteinsLepidopteraPest Control, BiologicalPlants, Genetically ModifiedZea maysBacillus thuringiensis ToxinsBacterial ProteinsEndotoxinsHemolysin Proteinsinsecticidal crystal protein, Bacillus ThuringiensisBacillus thuringiensiscontrol of insect pest larvaeenvironmental considerationsrecombinant organismssynergyδ-endotoxins

Identifiers

PMID21326834
PMCPMC3037584
OpenAlexW2045820212

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.